Ana Cobo
Overview
Explore the profile of Ana Cobo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cobo A, Coello A, De Los Santos M, Remohi J, Bellver J
Am J Obstet Gynecol
. 2024 Mar;
231(2):238.e1-238.e11.
PMID: 38527601
Background: Recently, the potential detrimental effect that the duration of storage time may have on vitrified samples has raised some concerns, especially when some studies found an association between cryostorage...
2.
Cimadomo D, Cobo A, Galliano D, Fiorentino G, Marconetto A, Zuccotti Prof M, et al.
Fertil Steril
. 2024 Jan;
121(4):555-561.
PMID: 38185200
Infertility is a condition with profound social implications. Indeed, it is not surprising that evolutions in both medicine and society affect the way in vitro fertilization is practiced. The keywords...
3.
Perez-Sanchez M, Pardinas M, Diez-Juan A, Quinonero A, Dominguez F, Martin A, et al.
J Assist Reprod Genet
. 2023 Oct;
40(11):2577-2589.
PMID: 37801195
Purpose: Does vitrification/warming affect the mitochondrial DNA (mtDNA) content and the gene expression profile of blastocysts? Methods: Prospective cohort study in which 89 blastocysts were obtained from 50 patients between...
4.
Giles J, Cruz M, Cobo A, Vidal C, Requena A, Remohi J, et al.
Reprod Biomed Online
. 2023 Jun;
47(2):103222.
PMID: 37290978
Research Question: Can medroxyprogesterone acetate (MPA) be used as a pituitary suppressor instead of a gonadotrophin releasing hormone (GnRH) antagonist during ovarian stimulation in elective fertility preservation and preimplantation genetic...
5.
Pellicer N, Cozzolino M, Diaz-Garcia C, Galliano D, Cobo A, Pellicer A, et al.
Reprod Biomed Online
. 2023 Jan;
46(3):543-565.
PMID: 36710157
The ovary has a comparatively short functional lifespan compared with other organs, and genetic and pathological injuries can further shorten its functional life. Thus, preserving ovarian function should be considered...
6.
Cobo A, Garcia-Velasco J, Remohi J, Pellicer A
Fertil Steril
. 2021 May;
115(5):1091-1101.
PMID: 33933172
Growing evidence of successful outcomes achieved with the oocyte vitrification technique has greatly contributed to its application in the field of fertility preservation (FP). The population that can benefit from...
7.
Coello A, Nohales M, Meseguer M, de Los Santos M, Remohi J, Cobo A
Reprod Biomed Online
. 2021 Mar;
42(5):881-891.
PMID: 33785304
Research Question: Which pre-vitrification parameters are the most predictive of survival and live birth in vitrified-warmed blastocyst transfer cycles? Design: A retrospective study including 11,936 warmed blastocysts. Pre-vitrification morphological parameters...
8.
Cobo A, Coello A, de Los Santos M, Giles J, Pellicer A, Remohi J, et al.
Reprod Biomed Online
. 2021 Feb;
42(4):725-732.
PMID: 33573907
Research Question: How does the number of oocytes used affect the cumulative live birth rate (CLBR) in endometriosis patients who had their oocytes vitrified for fertility preservation? Design: Retrospective observational...
9.
Cobo A, Giles J, Paolelli S, Pellicer A, Remohi J, Garcia-Velasco J
Fertil Steril
. 2020 Mar;
113(4):836-844.
PMID: 32145929
Objective: To describe the outcome of fertility preservation (FP) using vitrified oocytes in patients with endometriosis and to determine the impact of ovarian surgery. Design: Retrospective observational study. Setting: University-affiliated...
10.
Cobo A, Kuwayama M, Perez S, Ruiz A, Pellicer A, Remohi J
Fertil Steril
. 2019 Oct;
112(4 Suppl1):e85-e92.
PMID: 31623747
No abstract available.